Matches in SemOpenAlex for { <https://semopenalex.org/work/W2756377741> ?p ?o ?g. }
- W2756377741 endingPage "8" @default.
- W2756377741 startingPage "1" @default.
- W2756377741 abstract "To investigate efficacy, safety and survival of belimumab and to identify predictors of drug response and drug discontinuation in patients with active SLE in clinical practice.Data of SLE patients, treated with belimumab, from 11 Italian prospective cohorts were analyzed. SLEDAI-2K, anti-dsDNA, C3, C4, prednisone daily dose, DAS-28, 24-h proteinuria, CLASIa (Cutaneous LE Disease Area and Severity Index Activity) were recorded at baseline and every 6 months. SLE Responder Index-4 (SRI-4) was calculated at 12 and 24 months. Demographic and clinical features and comorbidities were included in the univariate and multivariate analysis. Adverse events were recorded at each visit. Statistics was performed using the SPSS software.We studied 188 SLE patients, mean follow-up 17.5 ± 10.6 months. The most frequent manifestations, which required the use of belimumab, were polyarthritis (45.2%) and skin rashes (25.5%). SRI-4 was achieved by 77.0% and 68.7% of patients at 12 and 24-months. Independent predictors of 12-month response were SLEDAI-2K ≥ 10 (OR 40.46, p = 0.001) and polyarthritis (OR 12.64, p = 0.001) and of 24-month response were SLEDAI-2K ≥ 10 (OR 15.97, p = 0.008), polyarthritis (OR 32.36, p = 0.006), and prednisone ≥7.5 mg/day (OR 9.94, p = 0.026). We observed a low rate of severe adverse events. Fifty-eight patients (30.8%) discontinued belimumab after a mean follow-up of 10.4 ± 7.5 months. The drug survival was 86.9%, 76.9%, 69.4%, 67.1%, and 61.9% at 6, 12, 18, 24, and 30 months, respectively. No factors associated with drug discontinuation were found.Belimumab is effective and safe when used in clinical practice setting." @default.
- W2756377741 created "2017-09-25" @default.
- W2756377741 creator A5006082336 @default.
- W2756377741 creator A5006096603 @default.
- W2756377741 creator A5013492063 @default.
- W2756377741 creator A5013612547 @default.
- W2756377741 creator A5022555111 @default.
- W2756377741 creator A5028722826 @default.
- W2756377741 creator A5037295594 @default.
- W2756377741 creator A5038161485 @default.
- W2756377741 creator A5040022818 @default.
- W2756377741 creator A5042259427 @default.
- W2756377741 creator A5047910651 @default.
- W2756377741 creator A5051145762 @default.
- W2756377741 creator A5051526168 @default.
- W2756377741 creator A5056105834 @default.
- W2756377741 creator A5057060255 @default.
- W2756377741 creator A5057585306 @default.
- W2756377741 creator A5061119590 @default.
- W2756377741 creator A5064846220 @default.
- W2756377741 creator A5066642738 @default.
- W2756377741 creator A5067139776 @default.
- W2756377741 creator A5068168029 @default.
- W2756377741 creator A5069436439 @default.
- W2756377741 creator A5074477451 @default.
- W2756377741 creator A5075020183 @default.
- W2756377741 creator A5079447134 @default.
- W2756377741 creator A5082768092 @default.
- W2756377741 creator A5084450056 @default.
- W2756377741 creator A5089912115 @default.
- W2756377741 date "2018-01-01" @default.
- W2756377741 modified "2023-10-14" @default.
- W2756377741 title "Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study" @default.
- W2756377741 cites W1966439074 @default.
- W2756377741 cites W2008934232 @default.
- W2756377741 cites W2018760896 @default.
- W2756377741 cites W2022729350 @default.
- W2756377741 cites W2053709659 @default.
- W2756377741 cites W2059163097 @default.
- W2756377741 cites W2060253834 @default.
- W2756377741 cites W2063420115 @default.
- W2756377741 cites W2091468965 @default.
- W2756377741 cites W2091679727 @default.
- W2756377741 cites W2097307571 @default.
- W2756377741 cites W2111511771 @default.
- W2756377741 cites W2119296184 @default.
- W2756377741 cites W2119837784 @default.
- W2756377741 cites W2130781410 @default.
- W2756377741 cites W2131457901 @default.
- W2756377741 cites W2136149088 @default.
- W2756377741 cites W2146203649 @default.
- W2756377741 cites W2156027405 @default.
- W2756377741 cites W2158263012 @default.
- W2756377741 cites W2158927265 @default.
- W2756377741 cites W2159541899 @default.
- W2756377741 cites W2166743393 @default.
- W2756377741 cites W2170524712 @default.
- W2756377741 cites W2241669093 @default.
- W2756377741 cites W2255119417 @default.
- W2756377741 cites W2327267263 @default.
- W2756377741 cites W2338584698 @default.
- W2756377741 cites W2345294951 @default.
- W2756377741 cites W2462648395 @default.
- W2756377741 cites W2479502793 @default.
- W2756377741 cites W2483802245 @default.
- W2756377741 cites W2511973024 @default.
- W2756377741 cites W2547795930 @default.
- W2756377741 cites W2549420521 @default.
- W2756377741 cites W2555873873 @default.
- W2756377741 cites W2558646790 @default.
- W2756377741 cites W2581200331 @default.
- W2756377741 cites W2584093778 @default.
- W2756377741 cites W2587800318 @default.
- W2756377741 cites W2593714154 @default.
- W2756377741 cites W2775607224 @default.
- W2756377741 doi "https://doi.org/10.1016/j.jaut.2017.09.004" @default.
- W2756377741 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28935492" @default.
- W2756377741 hasPublicationYear "2018" @default.
- W2756377741 type Work @default.
- W2756377741 sameAs 2756377741 @default.
- W2756377741 citedByCount "76" @default.
- W2756377741 countsByYear W27563777412018 @default.
- W2756377741 countsByYear W27563777412019 @default.
- W2756377741 countsByYear W27563777412020 @default.
- W2756377741 countsByYear W27563777412021 @default.
- W2756377741 countsByYear W27563777412022 @default.
- W2756377741 countsByYear W27563777412023 @default.
- W2756377741 crossrefType "journal-article" @default.
- W2756377741 hasAuthorship W2756377741A5006082336 @default.
- W2756377741 hasAuthorship W2756377741A5006096603 @default.
- W2756377741 hasAuthorship W2756377741A5013492063 @default.
- W2756377741 hasAuthorship W2756377741A5013612547 @default.
- W2756377741 hasAuthorship W2756377741A5022555111 @default.
- W2756377741 hasAuthorship W2756377741A5028722826 @default.
- W2756377741 hasAuthorship W2756377741A5037295594 @default.
- W2756377741 hasAuthorship W2756377741A5038161485 @default.
- W2756377741 hasAuthorship W2756377741A5040022818 @default.
- W2756377741 hasAuthorship W2756377741A5042259427 @default.